Cargando…

Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study

BACKGROUND: Inadequately controlled symptoms incur a substantial burden on patients with neuroendocrine tumors and carcinoid syndrome (CS). The effectiveness of telotristat ethyl (TE) with a somatostatin analog for uncontrolled CS diarrhea has been demonstrated in clinical trials and observational s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulke, Matthew H, Kennecke, Hagen F, Murali, Kris, Joish, Vijay N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485853/ https://www.ncbi.nlm.nih.gov/pubmed/34611437 http://dx.doi.org/10.2147/CMAR.S330429

Ejemplares similares

TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World
por: Strosberg, Jonathan, et al.
Publicado: (2019)

Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
por: Metz, David C, et al.
Publicado: (2020)

Telotristat ethyl for carcinoid syndrome diarrhoea
Publicado: (2019)

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
por: Pavel, Marianne, et al.
Publicado: (2018)

Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study
por: Morse, Michael A, et al.
Publicado: (2020)

In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension
por: Jiang, Wenjun, et al.
Publicado: (2018)

Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome
por: Dillon, Joseph S., et al.
Publicado: (2020)

Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes
por: Saavedra, Cristina, et al.
Publicado: (2019)

Developments in the treatment of carcinoid syndrome – impact of telotristat
por: Chan, David L, et al.
Publicado: (2018)

Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors
por: Li, Daneng, et al.
Publicado: (2022)

Telotristat ethyl reverses myxomatous changes in mice mitral valves
por: Wang, Xinmei, et al.
Publicado: (2022)

Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach
por: Gelhorn, Heather L., et al.
Publicado: (2016)

The journey from gene knockout to clinical medicine: telotristat and sotagliflozin
por: Rendell, Marc S
Publicado: (2019)

Direct costs of carcinoid syndrome diarrhea among adults in the United States
por: Dasari, Arvind, et al.
Publicado: (2019)

AmbuFlex: tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases
por: Schougaard, Liv Marit Valen, et al.
Publicado: (2016)

Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis
por: Anderson, Peter, et al.
Publicado: (2021)

New Developments in the Treatment of Neuroendocrine Tumours – RADIANT-4, NETTER-1 and Telotristat Etiprate
por: Sbardella, Emilia, et al.
Publicado: (2016)

Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT
por: Tsang, Erica S., et al.
Publicado: (2021)

Effect of patient-initiated versus fixed-interval telePRO-based outpatient follow-up: study protocol for a pragmatic randomised controlled study
por: Schougaard, Liv Marit Valen, et al.
Publicado: (2017)

An incidental finding of carcinoid tumor of the cystic duct
por: Lim, Hoang U., et al.
Publicado: (2013)

Patient-reported outcome (PRO) measurements in chronic and malignant diseases: ten years’ experience with PRO-algorithm-based patient-clinician interaction (telePRO) in AmbuFlex
por: Hjollund, Niels Henrik I., et al.
Publicado: (2023)

Urticaria as initial finding of a patient with carcinoid tumor
por: Cherrez Ojeda, Ivan, et al.
Publicado: (2015)

Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome
por: Hudgens, Stacie, et al.
Publicado: (2019)

"Carcinoide" /
por: Selem Zacarias, Anuar Antonio
Publicado: (1988)

Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US
por: Edelman, Steve, et al.
Publicado: (2020)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

Probing Real Sensory Worlds of Receivers with Unsupervised Clustering
por: Pfeiffer, Michael, et al.
Publicado: (2012)

Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data
por: Garg, Amit, et al.
Publicado: (2022)

Endobronchial Carcinoid and Concurrent Carcinoid Syndrome in an Adolescent Female
por: Cogen, Jonathan D., et al.
Publicado: (2016)

Primary Mesenteric Carcinoid Tumor Presenting with Carcinoid Syndrome
por: Shogbesan, Oluwaseun, et al.
Publicado: (2018)

Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World
por: King, Gentry, et al.
Publicado: (2022)

Malignant metastatic carcinoid presenting as brain tumor
por: Sundar, I. Vijay, et al.
Publicado: (2016)

The Carcinoid Syndrome
por: Strahan, Jack
Publicado: (1961)

Carcinoid of the Appendix
por: Guha, A. C., et al.
Publicado: (1952)

The Carcinoid Syndrome
Publicado: (1973)

Primary Testicular Carcinoid Tumor presenting as Carcinoid Heart Disease
por: Chikkaraddi, Manjunath L., et al.
Publicado: (2015)

Cases in a series of carcinoid syndrome and carcinoid heart disease
por: Mamotabo, R Matshela
Publicado: (2018)

Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer
por: Su, Alan, et al.
Publicado: (2023)

Prognostic nomogram for predicting long-term survival in bronchopulmonary carcinoid tumor patients receiving resection
por: Li, Qiao, et al.
Publicado: (2021)

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
por: Cheng, Wendy Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_slnjcjrf33en0q41lh9nm9cts2